Grown Rogue International (GRUSF) EPS (Diluted) Growth (1y) (2010 - 2025)
Grown Rogue International (GRUSF) EPS (Diluted) Growth (1y) (2010 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 65.33% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 5.88% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -394.16% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -12.15% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 105.88% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 2,383.26% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -16.09% |
| 10 | Grown Rogue International | 99.97 Mn | 92.67 Mn | 3.96 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 450,668,625.39% |
| Jun 30, 2025 | 122.32% |
| Jan 31, 2023 | 276.17% |
| Jan 31, 2022 | -1,434.31% |
| Jul 31, 2021 | 93.17% |
| Apr 30, 2021 | 11.13% |
| Jan 31, 2021 | 33.08% |
| Oct 31, 2020 | 101.26% |
| Jul 31, 2020 | -4.24% |
| Apr 30, 2020 | 21.79% |
| Jan 31, 2020 | 66.47% |
| Oct 31, 2019 | 16.90% |
| Jul 31, 2019 | 73.56% |
| Apr 30, 2019 | -41.57% |
| Jan 31, 2019 | -270.50% |
| Feb 28, 2018 | -7,873,428.94% |
| Nov 30, 2017 | 7,917,094.42% |
| Feb 28, 2017 | 201.66% |
| Nov 30, 2016 | 87.48% |
| Feb 29, 2016 | -135.73% |